Zobrazeno 1 - 10
of 23
pro vyhledávání: '"John Elvin"'
Publikováno v:
Journal of Manufacturing Technology Management, 2024, Vol. 35, Issue 3, pp. 544-567.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JMTM-05-2023-0173
Autor:
Huan Cao, John Elvin, Emma Gudgin, Andreas Neerincx, Brian J. P. Huntly, John Trowsdale, Bernard de Bono, Clare Pridans, Mark A. Vickers, Ursula Lakner, Catherine Huntington, Alexander D. Barrow
Publikováno v:
British journal of haematologyReferences. 193(5)
Sialic acid-binding immunoglobulin-like lectin (Siglec)-15 has recently been identified as a critical tumour checkpoint, augmenting the expression and function of programmed death-ligand 1. We raised a monoclonal antibody, A9E8, specific for Siglec-1
Autor:
Danielle Carroll, John Elvin, Simon T. Barry, Christine J. Rossant, Joris J. Benschop, Eldar E Kim, Frances Neal, Ling Huang, Edward H. Walker, Tristan J. Vaughan
Publikováno v:
mAbs. 6:1425-1438
Generation of functional antibodies against integral membrane proteins such as the G-protein coupled receptor CXCR2 is technically challenging for several reasons, including limited epitope accessibility, the requirement for a lipid environment to ma
Autor:
John Elvin, Douglas F. Nixon, John Gallwey, Andrew J. McMichael, Charles R. Rizza, Alain Townsend
Publikováno v:
Scopus-Elsevier
Current candidate vaccines fail to protect primates against challenge with human immunodeficiency virus (HIV) in the presence of antibody responses; this underlines the importance of studying cell-mediated immunity to HIV and identifying specific epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2814ab0f94608ca908749ddc2aa5d60
https://ora.ox.ac.uk/objects/uuid:584c88c7-2a2d-48e5-ab86-565e6596c3a6
https://ora.ox.ac.uk/objects/uuid:584c88c7-2a2d-48e5-ab86-565e6596c3a6
Publikováno v:
Scopus-Elsevier
In an attempt to define the structural features of peptides which are important for inducing the folding of free class I heavy chains in the absence of beta 2-microglobulin, and to determine whether they are the same as those required to form stable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7842694f3068b33ac80ed8abf436c17b
https://ora.ox.ac.uk/objects/uuid:5e1408b7-8113-46c6-a235-771a75fc5949
https://ora.ox.ac.uk/objects/uuid:5e1408b7-8113-46c6-a235-771a75fc5949
Autor:
Adrian V. S. Hill, John Elvin, Anthony C. Willis, Michael Aidoo, Catherine E. M. Allsopp, Frances M. Gotch, X. Ming Gao, Masafumi Takiguchis, Brian M. Greenwood, Alain R. M. Townsend, Andrew J. McMichael, Hilton C. Whittle
Publikováno v:
Scopus-Elsevier
The protective association between the human leukocyte antigen HLA-B53 and severe malaria was investigated by sequencing of peptides eluted from this molecule followed by screening of candidate epitopes from pre-erythrocytic-stage antigens of Plasmod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2158a01c43ebf328a800d0b38b18ca
https://ora.ox.ac.uk/objects/uuid:90b70f38-207e-410b-8727-d2a0501a734f
https://ora.ox.ac.uk/objects/uuid:90b70f38-207e-410b-8727-d2a0501a734f
Autor:
Sarah Rowland-Jones, Rodney E. Phillips, Frances M. Gotch, Jon Edwards, Folabi Ogunlesi, John Elvin, Charles R. Rizza, Douglas Fraser Nixon, Andrew James Mcmichael
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f23776a7f50101ce0cec2588fa829efd
https://doi.org/10.1159/000422209
https://doi.org/10.1159/000422209
Autor:
Sandrine Guillard, Anders Karlsson, Carl Hay, Robert E. Hollingsworth, Steven Rust, Max Davidson, Kris Sachsenmeier, Roger Karlsson, Ralph Minter, Matt Flynn, Lutz Jermutus, John Elvin, Erin Brand, David Lowne, Gene Kurosawa
Publikováno v:
Molecular Cancer, Vol 12, Iss 1, p 11 (2013)
Molecular Cancer
Molecular Cancer
Background The continued discovery of therapeutic antibodies, which address unmet medical needs, requires the continued discovery of tractable antibody targets. Multiple protein-level target discovery approaches are available and these can be used in
Publikováno v:
International journal of pharmaceutics. 440(1)
Antibodies are well established in mainstream clinical practice and present an exciting area for collaborative research and development in industry and academia alike. In this review, we will provide an overview of the current market and an outlook t